MASI logo

MASIMasimo Corp

$179.95
$0.01
(0.01%)
Today
Updated: 04:00 PM EDT
EarningsAug 4
Mkt Cap$9.42B
Vol3.16M
46

Neutral Sentiment

How do you feel about MASI?

News
all
press releases
SIRI Stock Surges 5% After-Hours On S&P MidCap 400 Inclusion
The index provider said Sirius XM will take Masimo’s (MASI) slot in the benchmark effective prior to the market open on Thursday, June 11.
Stocktwits
News Placeholder
More News
News Placeholder
Integer Holdings 2026 Outlook: Drivers, Risks, Valuation
ITGR resets its 2026 outlook after customer forecast changes and slower product ramps, with growth and margin recovery tied to adoption timing.
Zacks
News Placeholder
IART vs. MASI: Which Stock Should Value Investors Buy Now?
IART vs. MASI: Which Stock Is the Better Value Option?
Zacks
News Placeholder
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of +64.79% and -56.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
IART or MASI: Which Is the Better Value Stock Right Now?
IART vs. MASI: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates
Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of -127.78% and +6.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of -14.09% and +0.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Masimo Shareholders Approve Acquisition by Danaher
Masimo Corporation (Nasdaq: MASI) (Masimo), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced...
Business Wire
News Placeholder
Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones
MASI's SET pulse oximetry shows accurate, consistent readings in hospitalized newborns across all skin tones in the largest real-world study.
Zacks
News Placeholder
Masimo Corporation (NASDAQ:MASI) Short Interest Update
Masimo Corporation (NASDAQ:MASI - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 3,818,925...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.